Literature DB >> 23530026

Improving mitral valve coaptation with adjustable rings: outcomes from a European multicentre feasibility study with a new-generation adjustable annuloplasty ring system.

Francesco Maisano1, Volkmar Falk, Michael A Borger, Hugo Vanermen, Ottavio Alfieri, Joerg Seeburger, Stefan Jacobs, Michael Mack, Friederich W Mohr.   

Abstract

OBJECTIVES: To evaluate the performance and safety of an adjustable semi-rigid annuloplasty ring for mitral regurgitation (MR) in a multicentre study.
METHODS: Between March 2010 and December 2011, 30 subjects underwent mitral valve (MV) repair using the Cardinal adjustable annuloplasty ring. This device is a semi-rigid ring allowing postimplantation size adjustment, under beating-heart conditions, to optimize leaflet coaptation under echocardiographic guidance. Coaptation length was determined before and after adjustment by transoesophageal echocardiography.
RESULTS: The study enrolled 21 (70%) male and 9 (30%) female subjects with a mean age of 64 years. The approach was conventional midline sternotomy or mini-invasive right thoracotomy. Leaflet resection was done in 17 subjects, and chordal repair was used in 13. Concomitant procedures included coronary artery bypass grafting in 2 (7%) subjects, atrial ablation in 4 (13%) and tricuspid repair in 4 (13%). There was 1 (3%) early death unrelated to the study device. Intraoperative ring adjustment was performed in 24 of the 30 subjects. Residual MR was detected prior to adjustment in 6 subjects (4 mild and 2 moderate MR). Following adjustment, 5 subjects had no MR and 1 had trace MR. After adjustment, mean coaptation length improved from 7 ± 3 to 10 ± 3 mm (P < 0.0001). All patients who completed 1-year follow-up had less-than-mild MR, with the exception of 1 patient with ring dehiscence (and resultant 2+ MR) and 1 functional MR patient who developed recurrent 2+ MR due to persistent leaflet tethering.
CONCLUSIONS: MV repair with the Cardinal adjustable annuloplasty ring is a reliable technique that enables the adjustment of the ring diameter on a beating heart under echocardiographic control. Such technology allows the optimization of leaflet coaptation, providing minimal residual MR and durable repair.

Entities:  

Keywords:  Annuloplasty; Coaptation length; Echocardiography; Image-guided surgery; Mitral valve; Reconstruction; Repair

Mesh:

Year:  2013        PMID: 23530026     DOI: 10.1093/ejcts/ezt128

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  5 in total

1.  Results of mitral valve repair with an adjustable annuloplasty ring 2 years after implantation.

Authors:  Simon H Sündermann; Markus Czesla; Jörg Kempfert; Thomas Walther; Patrick Nataf; Ehud Raanani; Stephan Jacobs; Ottavio Alfieri; Francesco Maisano; Volkmar Falk
Journal:  Heart Vessels       Date:  2016-12-23       Impact factor: 2.037

2.  Effect of mitral annuloplasty device shape and size on leaflet and myofiber stress following repair of posterior leaflet prolapse: a patient-specific finite element simulation.

Authors:  William G Morrel; Liang Ge; Zhihong Zhang; Eugene A Grossi; Julius M Guccione; Mark B Ratcliffe
Journal:  J Heart Valve Dis       Date:  2014-11

Review 3.  Mitral Valve Interventions in Structural Heart Disease.

Authors:  Matteo Saccocci; Maurizio Taramasso; Francesco Maisano
Journal:  Curr Cardiol Rep       Date:  2018-05-17       Impact factor: 2.931

4.  Safety and feasibility of a novel adjustable mitral annuloplasty ring: a multicentre European experience.

Authors:  Martin Andreas; Nicolas Doll; Steve Livesey; Manuel Castella; Alfred Kocher; Filip Casselman; Vladimir Voth; Christina Bannister; Juan F Encalada Palacios; Daniel Pereda; Guenther Laufer; Markus Czesla
Journal:  Eur J Cardiothorac Surg       Date:  2015-02-17       Impact factor: 4.191

5.  Design, Analysis and Testing of a Novel Mitral Valve for Transcatheter Implantation.

Authors:  Selim Bozkurt; Georgia L Preston-Maher; Ryo Torii; Gaetano Burriesci
Journal:  Ann Biomed Eng       Date:  2017-04-03       Impact factor: 3.934

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.